Form 4: Generation Bio Co. CFO Matthew Norkunas Reports Stock Transactions

Matthew Norkunas, CFO of Generation Bio Co., reports acquisition and disposal of common stock and restricted stock units on July 15, 2024.

Summary

• On July 15, 2024, Matthew Norkunas, the Chief Financial Officer of Generation Bio Co., engaged in transactions involving the company's common stock and restricted stock units.
• Norkunas acquired 1,674 shares of common stock through the vesting of restricted stock units.
• He also disposed of 492 shares of common stock to cover tax obligations at a price of $2.93 per share.
• Additionally, he acquired 1,673 shares of common stock through the vesting of another set of restricted stock units and disposed of 492 shares to cover tax obligations at $2.93 per share.
• Following these transactions, Norkunas directly owns 54,985 shares of Generation Bio Co. common stock and 3,346 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock transactions by a company insider, with no inherently positive or negative implications.

Positives

• The vesting of restricted stock units indicates that Norkunas is meeting the conditions of his equity compensation plan, aligning his interests with the company's performance.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.

Key Dates